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background: The nationwide safety outcomes and the role of catheter-directed thrombolysis (CDT) in the treatment of deep vein thrombosis (DVT) 
in patients with chronic kidney disease (CKD) are unknown.
methods: We used the Nationwide Inpatient Sample database from 2005 to 2011 to identify all patients admitted with a principal discharge 
diagnosis of proximal lower extremity and caval DVT in patients with chronic kidney disease. In these patients, we evaluated the in-hospital 
outcomes and trends in the utilization rates of CDT. We compared in-hospital outcomes between the matched groups treated with CDT plus 
anticoagulation (Group A - 306 patients) vs. anticoagulation alone (Group B - 306). We used propensity scores and Elixhauser comorbidity index to 
match the two treatment groups.
results: Among a total of 11,613 CKD patients admitted with principal discharge diagnosis of proximal lower extremity or caval DVT, 2.7% (309) 
underwent CDT. The national CDT utilization rates in these patients gradually increased from 1.4% in 2005 to 3.4% in 2011. Females were less 
likely to be treated with thrombolysis (2.1% versus 3.3%; p <0.001). In-hospital mortality was not significantly different between the CDT group 
and the anticoagulation alone group (2.9% versus 1.3%; p= 0.262). The rates of blood transfusion, pulmonary embolism, intracranial bleeding, 
vena caval filter placement, and acute renal failure were significantly higher in the CDT group. The CDT group also had significantly increased length 
of stay (9.97±9.1 vs. 6.83±5.5 days; p<0.001) and hospital charges ($104334 ± 80789 vs. $42141 ± 59031; p<0.001) when compare to the 
anticoagulation alone group.
conclusions: In this nationwide observational study of CKD patients, we found that in-hospital morbidity with CDT remains higher than 
anticoagulation alone, however the in-hospital mortality was not significantly different between the two groups.
